Clinical Trials

BreastGastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms

NCT05143970 2026-03-20

CHANCES

Phase 1 Recruiting

27 enrolled

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT03785574 2026-03-16

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

30 enrolled

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Phase 3 Recruiting

580 enrolled

GastrointestinalGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms

NCT07033819 2026-02-27

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

48 enrolled

Ovarian Neoplasms

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Phase 3 Recruiting

710 enrolled

Neoplasms, Endometrial Neoplasms

NCT07340489 2026-01-14

Serplulimab for Locally Advanced Cervical Cancer

216 enrolled

Uterine Cervical Neoplasms

NCT06727617 2026-01-06

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

134 enrolled

Uterine Cervical Neoplasms

NCT06529809 2025-12-24

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Phase 1/2 Recruiting

50 enrolled

Uterine Cervical Neoplasms

NCT07167160 2025-12-18

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

59 enrolled

Uterine Cervical Neoplasms

NCT07286240 2025-12-16

QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer

40 enrolled

Treatment of Recurrent Ovarian Cancer

NCT06877572 2025-10-27

ECS Weight

Recruiting

50 enrolled

Endometrial Neoplasms

NCT06686030 2025-04-16

Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

150 enrolled

Platinum-sensitive Ovarian Cancer

NCT05857631 2025-04-15

PARCERII

90 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06560112 2025-03-12

An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

172 enrolled

Ovarian Neoplasms

NCT05704621 2025-03-06

SOCCER-P

124 enrolled

Neoplasms, Ovarian Neoplasms

NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

51 enrolled

Hypoxia, Uterine Cervical Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

1,615 enrolled

Endometrial Neoplasms

NCT06692166 2024-11-22

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

Phase 3 Recruiting

420 enrolled

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT05684731 2024-08-13

K19017-004

Phase 1 Recruiting

30 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Ovarian Neoplasms

NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Phase 2/3 Recruiting

200 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06376604 2024-04-19

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

30 enrolled

Intermittent Fasting, Ovarian Neoplasms

NCT05076942 2023-08-01

GROINSS-VIII

157 enrolled

Lymphatic Metastasis, Vulvar Neoplasms

NCT05733806 2023-02-23

MITO9B

Recruiting

500 enrolled

Gynecologic Cancer

NCT05607329 2022-11-07

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

400 enrolled